WO2008014198A1 - Lipoxygenase enzyme assay - Google Patents

Lipoxygenase enzyme assay Download PDF

Info

Publication number
WO2008014198A1
WO2008014198A1 PCT/US2007/074075 US2007074075W WO2008014198A1 WO 2008014198 A1 WO2008014198 A1 WO 2008014198A1 US 2007074075 W US2007074075 W US 2007074075W WO 2008014198 A1 WO2008014198 A1 WO 2008014198A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipoxygenase
assay
enzyme
lipoxygenase enzyme
reagent
Prior art date
Application number
PCT/US2007/074075
Other languages
French (fr)
Inventor
John Alan Broadwater
Hnin Hnin Khine
Kristine Woodruff
Original Assignee
Boehringer Ingelheim International Gmbh
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharma Gmbh & Co. Kg filed Critical Boehringer Ingelheim International Gmbh
Priority to US12/373,540 priority Critical patent/US20090253158A1/en
Publication of WO2008014198A1 publication Critical patent/WO2008014198A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Definitions

  • TECHNICAL FIELD This invention relates to methods and kits for lipoxygenase enzymes which catalyze the oxygen-dependent oxidation of fatty acid substrates (linoleic acid and arachidonic acid are common examples) to form hydroperoxy-fatty acid products.
  • the methods and kits are useful for detecting inhibitors of such enzymes.
  • Lipoxygenase enzymes catalyze the oxygen-dependent oxidation of fatty acid substrates (linoleic acid and arachidonic acid are common examples) to form hydroperoxy-fatty acid products. Enzymes have been purified from diverse organisms that display a broad range of substrate specificity and product specificity (i.e. the site of oxidiation within the fatty acid).
  • Another assay that has been used is to determine the concentration of hydroperoxy (or the chemically-reduced hydroxy-derivatives) fatty acids by separation from the substrate on a high-performance liquid chromatography (HPLC) system (for example, Yamamoto et al. (1990) Methods in Enzymology, 186, 371-380).
  • HPLC high-performance liquid chromatography
  • the color- forming reagent is added and the color is measured on a spectrophotometer.
  • One assay used a xylenol orange :iron(II) complex (Waslidge et al. (1995) Anal. Biochemistry, 231, 354-358) and the second assay used hemoglobin as the catalyst) and N-benzoyl leucomethylene (Auerbach et al. (1992) Anal. Biochemistry, 201, 375-380) as the colorimetric reagent.
  • These assays offer improved sensitivity over the direct spectrophotometric assay ( ⁇ 10-fold) and improved throughput when compared to the HPLC method.
  • the present inventors have designed an assay format to enable the identification of inhibitors of lipoxygenase enzymes. This assay represents a significant advantage over previous assay formats as the sensitivity and uniqueness of the signal render the format more amenable to high-throughput screening.
  • Figure 1 Schematic depiction of microperoxidase catalyzing a redox reaction between the hydroperoxy-fatty acid product and the Amplex UltraRed® to generate the highly fluorescent product resorufin. The amount of resorufin is then determined using fluorescence spectroscopy.
  • Figure 2 Schematic depiction of the fluorometric lipoxygenase assay that would be used to characterize the activity of a 15 -lipoxygenase.
  • Figures 3-5 Inhibition of x-lipoxygenase by representative compounds of varying potencies.
  • the y-axis is Percent of Control and the x-axis units are in microM.
  • the present invention provides a new assay for lipoxygenase which is an improvement from the historical assays described above.
  • the lipoxygenase has been incubated with the fatty acid substrate (linoleic acid or arachidonic acid) and oxygen, microperoxidase (a catalyst) and Amplex UltraRed® are added.
  • the microperoxidase catalyzes a redox reaction between the hydroperoxy-fatty acid product and the Amplex UltraRed® to generate the highly fluorescent product resorufin.
  • the amount of resorufin is then determined using fluorescence spectroscopy (excitation at 530 nm and emission at 580 nm). See figure 1.
  • This assay improves the sensitivity ⁇ 10-fold over that observed in the colorimetric assays and generates a fluorescent signal that is both stable and free from compound interference as very few compounds fluoresce in this range.
  • kits for determining the amount of lipoxygenase enzyme inhibition by a test compound comprising: a lipoxygenase enzyme; a lipoxygenase enzyme substrate; oxygen; a peroxidase and a fluorometric reagent.
  • the above kit can further contain a positive control that comprises a mock test compound.
  • Said mock test compound having no or negligible lipoxygenase enzyme inhibition.
  • the Enzymes have been purified from diverse organisms that display a broad range of substrate specificity and product specificity.
  • the assay as it is routinely performed is summarized in the scheme from the example section below but alterations apparent to those of ordinary skill in the art can be made. For instance, the incubation time or temperature can be adjusted but it is ideal to adjust them such that the enzyme activity is within the linear response range.
  • the assay has been performed at various scales (cuvet, 96 or 384 well) and is expected to work at any scale required within any desired reaction vessel (e.g. polypropylene micro-plate or polystyrene cuvet).
  • Any substrate of the lipoxygenase enzyme can be used; this could include, but is not limited to, free fatty acids or esterified fatty acids of varying composition (e.g. arachidonic acid, linoleyl- phosphatidyl choline, low-density lipoprotein, etc.).
  • Amplex UltraRed® is the preferred fluorometric reagent in this protocol
  • Amplex Red® or any reagent that results in the production of a fluorescent molecule with similar fluorescence can also be used.
  • microperoxidase may be substituted with any peroxidase that catalyzes the reaction between the hydroperoxide product and the fluorometric reagent (i.e. Amplex UltraRed® in the preferred embodiment).
  • the solutions used for the lipoxygenase reaction and the microperoxidase reaction may also be modified from the specified conditions so long as activity of the lipoxygenase and microperoxidase catalysts are retained. Examples of the use of this assay identify lipoxygenase inhibitors are shown in figures 3-5.
  • the Assay according to the invention can be performed according to the scheme shown in figure 2.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

A method for identifying inhibitors of a lipoxygenase enzyme, the assay comprising: contacting a lipoxygenase enzyme with a test Compound, a lipoxygenase enzyme Substrate and oxygen; adding a f luorometric reagent and a peroxidase; measuring the fluorescent signal; determining the amount of enzyme inhibition by the test Compound.

Description

Lipoxygenase Enzyme Assay
BACKGROUND OF THE INVENTION
APPLICATION DATA
This application claims benefit to US provisional application serial no. 60/820,390 filed July 26, 2006.
1. TECHNICAL FIELD This invention relates to methods and kits for lipoxygenase enzymes which catalyze the oxygen-dependent oxidation of fatty acid substrates (linoleic acid and arachidonic acid are common examples) to form hydroperoxy-fatty acid products. The methods and kits are useful for detecting inhibitors of such enzymes.
2. BACKGROUND INFORMATION
Lipoxygenase enzymes catalyze the oxygen-dependent oxidation of fatty acid substrates (linoleic acid and arachidonic acid are common examples) to form hydroperoxy-fatty acid products. Enzymes have been purified from diverse organisms that display a broad range of substrate specificity and product specificity (i.e. the site of oxidiation within the fatty acid).
Several assay procedures have been published in the literature but each has particular limitations that make high-throughput screening difficult. The simplest assay is the spectrophotometric monitoring of the hydroperoxy-fatty acid product; the hydroperoxy- moiety absorbs light at 234 nm and can therefore be easily monitored with a spectrophotometer. As many potential inhibitors absorb light at this wavelength, this assay format is prone to interference from the very compounds we seek. Another method of assaying for lipoxygenase activity is to monitor the consumption of oxygen using a Clark electrode; this method is neither sensitive nor amenable to high- throughput. Another assay that has been used is to determine the concentration of hydroperoxy (or the chemically-reduced hydroxy-derivatives) fatty acids by separation from the substrate on a high-performance liquid chromatography (HPLC) system (for example, Yamamoto et al. (1990) Methods in Enzymology, 186, 371-380). These assays, while accurate, are heterogeneous and time consuming and are therefore not amenable to screening large numbers of compounds. Two different colorimetric assay formats have been developed that utilize the oxidation state of the hydroperoxy product to couple product formation to color formation. Both assays are conducted in two steps and differ on the colorimetric reagent. After product has been formed, the color- forming reagent is added and the color is measured on a spectrophotometer. One assay used a xylenol orange :iron(II) complex (Waslidge et al. (1995) Anal. Biochemistry, 231, 354-358) and the second assay used hemoglobin as the catalyst) and N-benzoyl leucomethylene (Auerbach et al. (1992) Anal. Biochemistry, 201, 375-380) as the colorimetric reagent. These assays offer improved sensitivity over the direct spectrophotometric assay (~ 10-fold) and improved throughput when compared to the HPLC method. However, colorimetric assays suffer from a small signal-to-background window in which to measure a signal. Kratky et al. have published a very sensitive assay of lipoxygenases based upon chemiluminescent detection (Kratky et al. (1999) Biochimica et Biophyscia Acta, 1437, 13-22). The hydroperoxy-fatty acid product of lipoxygenase is reacted with isoluminol and microperoxidase to form an electronically excited form of 4-aminophthalate that emits a photon upon its decay. Because chemiluminescence is very short lived, each individual assay must be initiated and completed before proceeding to the next assay. This process makes the assay unsuitable for a high-throughput approach.
Molecular Probes (now part of Invitrogen) has published an assay for hydrogen peroxide detection that employs Amplex Red® (N-acetyl-3,7-dihydroxyphenoxazine) or Amplex UltraRed® and uses horseradish peroxidase as the redox catalyst instead of microperoxidase (Zhou et al. (1997) Anal. Biochemistry, 253, 162-168). While they sell many kits based upon the ability to couple hydrogen peroxide with Ample Red® oxidation, they do not mention the ability use the Amplex Red® reagent to detect hydroperoxy-fatty acids nor do any of their present reagents use microperoxidase as the redox catalyst.
The present inventors have designed an assay format to enable the identification of inhibitors of lipoxygenase enzymes. This assay represents a significant advantage over previous assay formats as the sensitivity and uniqueness of the signal render the format more amenable to high-throughput screening. BRIEF SUMMARY OF THE INVENTION
It is therefore an object of the invention to provide a method to identify inhibitor of lipoxygenase enzymes.
It is a further object of the invention to provide a kit comprising an assay to identify inhibitor of lipoxygenase enzymes.
BRIEF DESCRIPTION OF THE FIGURES
Figure 1 : Schematic depiction of microperoxidase catalyzing a redox reaction between the hydroperoxy-fatty acid product and the Amplex UltraRed® to generate the highly fluorescent product resorufin. The amount of resorufin is then determined using fluorescence spectroscopy.
Figure 2: Schematic depiction of the fluorometric lipoxygenase assay that would be used to characterize the activity of a 15 -lipoxygenase.
Figures 3-5: Inhibition of x-lipoxygenase by representative compounds of varying potencies. The y-axis is Percent of Control and the x-axis units are in microM.
DETAILED DESCRIPTION OF THE INVENTION
To increase assay sensitivity and retain high-throughput features (homogenous assay that can be easily automated), the present invention provides a new assay for lipoxygenase which is an improvement from the historical assays described above. After the lipoxygenase has been incubated with the fatty acid substrate (linoleic acid or arachidonic acid) and oxygen, microperoxidase (a catalyst) and Amplex UltraRed® are added. The microperoxidase catalyzes a redox reaction between the hydroperoxy-fatty acid product and the Amplex UltraRed® to generate the highly fluorescent product resorufin. The amount of resorufin is then determined using fluorescence spectroscopy (excitation at 530 nm and emission at 580 nm). See figure 1. This assay improves the sensitivity ~ 10-fold over that observed in the colorimetric assays and generates a fluorescent signal that is both stable and free from compound interference as very few compounds fluoresce in this range.
In the broadest generic embodiment, there is provided a method for identifying inhibitors of lipoxygenase enzymes, the assay comprising:
contacting a lipoxygenase enzyme with a test compound, a lipoxygenase enzyme substrate and oxygen; adding a fluorometric reagent and a peroxidase; measuring the fluorescent signal; determining the amount of enzyme inhibition by the test compound.
In second generic embodiment, there is provided a kit for determining the amount of lipoxygenase enzyme inhibition by a test compound comprising: a lipoxygenase enzyme; a lipoxygenase enzyme substrate; oxygen; a peroxidase and a fluorometric reagent.
The above kit can further contain a positive control that comprises a mock test compound. Said mock test compound having no or negligible lipoxygenase enzyme inhibition.
The Enzymes have been purified from diverse organisms that display a broad range of substrate specificity and product specificity. The assay as it is routinely performed is summarized in the scheme from the example section below but alterations apparent to those of ordinary skill in the art can be made. For instance, the incubation time or temperature can be adjusted but it is ideal to adjust them such that the enzyme activity is within the linear response range. The assay has been performed at various scales (cuvet, 96 or 384 well) and is expected to work at any scale required within any desired reaction vessel (e.g. polypropylene micro-plate or polystyrene cuvet). Any lipoxygenase enzyme that produces a hydroperoxy product, irrespective of stereo- specificity, is capable of being assayed by this technique, including 15 -lipoxygenase from humans or soybean, 12-lipoxygenase and 5 -lipoxygenase. Any substrate of the lipoxygenase enzyme can be used; this could include, but is not limited to, free fatty acids or esterified fatty acids of varying composition (e.g. arachidonic acid, linoleyl- phosphatidyl choline, low-density lipoprotein, etc.). While Amplex UltraRed® is the preferred fluorometric reagent in this protocol, Amplex Red® or any reagent that results in the production of a fluorescent molecule with similar fluorescence (excitation maximum of 530 ± 25nm and emission maximum of 580 ± 25nm) can also be used. Similarly, microperoxidase may be substituted with any peroxidase that catalyzes the reaction between the hydroperoxide product and the fluorometric reagent (i.e. Amplex UltraRed® in the preferred embodiment). The solutions used for the lipoxygenase reaction and the microperoxidase reaction may also be modified from the specified conditions so long as activity of the lipoxygenase and microperoxidase catalysts are retained. Examples of the use of this assay identify lipoxygenase inhibitors are shown in figures 3-5.
EXAMPLES
The following examples are offered to illustrate, but not to limit the present invention.
The Assay according to the invention can be performed according to the scheme shown in figure 2.
All referenced cited in this application are incorporated herein by reference in their entirety.

Claims

What is Claimed is:
1. A method for identifying inhibitors of a lipoxygenase enzyme, the assay comprising:
contacting a lipoxygenase enzyme with a test compound, a lipoxygenase enzyme substrate and oxygen; adding a fluorometric reagent and a peroxidase; measuring the fluorescent signal; determining the amount of enzyme inhibition by the test compound.
2. The method according to claim 1 wherein the lipoxygenase enzymes are chosen from 15 -lipoxygenase, 12-lipoxygenase and 5 -lipoxygenase.
3. The method according to claim 2 wherein the substrate of the lipoxygenase enzyme is a free fatty acid or esterifϊed fatty acid.
4. The method according to claim 3 wherein the fluorometric reagent is a reagent that results in the production of a fluorescent molecule with an excitation maximum of 530 ± 25nm and emission maximum of 580 ± 25nm.
5. The method according to claim 4 wherein
the fluorometric reagent is Amplex UltraRed® and the peroxidase is microperoxidase.
6. A kit for determining the amount of lipoxygenase enzyme inhibition by a test compound comprising: a lipoxygenase enzyme; a lipoxygenase enzyme substrate; oxygen; a peroxidase and a fluorometric reagent.
7. The kit according to claim 6 further comprising a positive control.
PCT/US2007/074075 2006-07-26 2007-07-23 Lipoxygenase enzyme assay WO2008014198A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/373,540 US20090253158A1 (en) 2006-07-26 2007-07-23 Lipoxygenase Enzyme Assay

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82039006P 2006-07-26 2006-07-26
US60/820,390 2006-07-26

Publications (1)

Publication Number Publication Date
WO2008014198A1 true WO2008014198A1 (en) 2008-01-31

Family

ID=38610715

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/074075 WO2008014198A1 (en) 2006-07-26 2007-07-23 Lipoxygenase enzyme assay

Country Status (2)

Country Link
US (1) US20090253158A1 (en)
WO (1) WO2008014198A1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520006A1 (en) * 1982-01-21 1983-07-22 Toyo Jozo Kk PROCESS FOR THE QUANTITATIVE MEASUREMENT OF UNSATURATED FATTY ACIDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5406716B2 (en) * 2006-08-07 2014-02-05 アイアンウッド ファーマシューティカルズ インコーポレイテッド Indole compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2520006A1 (en) * 1982-01-21 1983-07-22 Toyo Jozo Kk PROCESS FOR THE QUANTITATIVE MEASUREMENT OF UNSATURATED FATTY ACIDS

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANTHON GORDON E ET AL: "Colorimetric method for the determination of lipoxygenase activity", JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, vol. 49, no. 1, January 2001 (2001-01-01), pages 32 - 37, XP002456826, ISSN: 0021-8561 *
AUERBACH B J ET AL: "A SPECTROPHOTOMETRIC MICROTITER-BASED ASSAY FOR THE DETECTION OF HYDROPEROXY DERIVATIVES OF LINOLEIC ACID", ANALYTICAL BIOCHEMISTRY, vol. 201, no. 2, 1992, pages 375 - 380, XP009091677, ISSN: 0003-2697 *
CATHCART R ET AL: "DETECTION OF PICOMOLE LEVELS OF HYDRO PER OXIDES USING A FLUORESCENT DI CHLORO FLUORESCEIN ASSAY", ANALYTICAL BIOCHEMISTRY, vol. 134, no. 1, 1983, pages 111 - 116, XP009091584, ISSN: 0003-2697 *
KRATKY DAGMAR ET AL: "A sensitive chemiluminescence method to measure the lipoxygenase catalyzed oxygenation of complex substrates", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1437, no. 1, 29 January 1999 (1999-01-29), pages 13 - 22, XP004277168, ISSN: 0006-3002 *
ZHOU MINGJIE ET AL: "A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases", ANALYTICAL BIOCHEMISTRY, vol. 253, no. 2, 15 November 1997 (1997-11-15), pages 162 - 168, XP002456845, ISSN: 0003-2697 *

Also Published As

Publication number Publication date
US20090253158A1 (en) 2009-10-08

Similar Documents

Publication Publication Date Title
Zyryanov et al. Rational design of a fluorescence-turn-on sensor array for phosphates in blood serum
EP0496793B1 (en) Enhanced chemiluminescent assay
Xu et al. BSA–tetraphenylethene derivative conjugates with aggregation-induced emission properties: Fluorescent probes for label-free and homogeneous detection of protease and α1-antitrypsin
US20020137027A1 (en) Bioanalytical measuring method using oxidases and lanthanoid-ligand complexes
US6617123B1 (en) Method for detection of 4-hydroxybutyric acid and its precursor(s) in fluids
Vojinović et al. Assay of H2O2 by HRP catalysed co-oxidation of phenol-4-sulphonic acid and 4-aminoantipyrine: characterisation and optimisation
EP0775215B1 (en) Chemiluminescence assays based on indoxyl substrates or thioindoxyl substrates
KR20190074231A (en) Microfluidic paper chip for detecting micro-organism, method for preparing the same and method for detecting micro-organism using the same
CN106383237A (en) A dry-sheet type serum creatinine detection reagent strip and a preparing method thereof
Yao et al. A highly sensitive and low-background fluorescence assay for pesticides residues based on hybridization chain reaction amplification assisted by magnetic separation
WO2019049966A1 (en) Histamine detection method and kit
US20090253158A1 (en) Lipoxygenase Enzyme Assay
WO2007011778A2 (en) Use of raman spectroscopy in enzyme activity assays
US20010014462A1 (en) Direct cholesterol esterase assay
Huang et al. Design and synthesis of a long-wavelength latent fluorogenic substrate for salicylate hydroxylase: a useful fluorimetric indicator for analyte determination by dehydrogenase-coupled biosensors
Lee et al. Sensitive Electrochemical Detection of Horseradish Peroxidase at Disposable Screen‐Printed Carbon Electrode
WO2012050536A1 (en) Method of the adenosine diphosphate quantitative determination
Yu et al. Employment of bromophenol red and bovine serum albumin as luminol signal co-enhancer in chemiluminescent detection of sequence-specific DNA
EP1641938A2 (en) Nucleic acid polymerase fluorescence assays
Aoyama et al. A novel ESR method for horseradish peroxidase activity using a combination of p-acetamidophenol and hydroxylamine, and its application to enzyme immunoassays
CA2324344A1 (en) Fluorescent assay for topoisomerase inhibitors
US20230109434A1 (en) Cell-free biosensors to detect creatinine, creatine, and sarcosine
Pinijsuwan et al. Development of a lipase-based optical assay for detection of DNA
Cai et al. Author’s Accepted Manuscript
Vázquez et al. Utilization of substrate-induced quenching for screening targets promoting NADH and NADPH consumption

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07813202

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12373540

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07813202

Country of ref document: EP

Kind code of ref document: A1